BioCryst Pharmaceuticals
Price & Volume
Stats
See moreOpen | $9.41 |
Previous Close | $9.41 |
Day Range | $9.37-$9.68 |
52W Range | $6-$11.31 |
Market Cap | $2.3B |
Shares Short | 35M |
Financials
See moreRevenue (12 Mos) | $874.8M |
Revenue Growth (YoY) | 209.1% |
Gross Profit (12 Mos) | $691.6M |
Diluted EPS | $1.21 |
News
See moreYahoo Finance • 9 days ago
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
Yahoo Finance • 27 days ago
BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?
Yahoo Finance • last month
BioCryst Pharma (BCRX) Subject to Prise Target Raise by Wedbush
Yahoo Finance • last month
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Charles K. Gayer |
CFO | Mr. Babar Ghias |
Address | 4505 Emperor Boulevard, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 435 |
